GPR63 Products

Antibodies
GPR63 Antibody
GPR63 Antibody
NBP1-82362
Species: Hu
Applications: WB, IHC, IHC-P
Host: Rabbit Polyclonal
GPR63 Antibody
GPR63 Antibody
NLS6379
Species: Hu, Bt, Mk, Pm, Canine, Equine, Mouse, Opossum, Porcine, Rabbit, Rat
Applications: IHC-P
Host: Rabbit Polyclonal
GPR63 Antibody
GPR63 Antibody
NLS6354
Species: Hu, Mu, Rt, Bt, Bv, Eq, Canine, Primate, Porcine, Rabbit, Monkey
Applications: IHC-P
Host: Rabbit Polyclonal
Lysates
GPR63 Overexpression Lysate ( ...
GPR63 Overexpression Lysate (Native)
NBP2-09700
Applications: WB
GPR63 Overexpression Lysate ( ...
GPR63 Overexpression Lysate (Native)
NBP2-06183
Applications: WB
Proteins
GPR63 Recombinant Protein Ant ...
GPR63 Recombinant Protein Antigen
NBP1-82362PEP
Species: Hu
Applications: AC
GPR63 Recombinant Protein
GPR63 Recombinant Protein
H00081491-G01
Species: Hu
RNAi
GPR63 RNAi
GPR63 RNAi
H00081491-R02
Species: Hu
Applications: RNAi, RNAi SP

Description

GPR63 (PSP24 Beta) is a Lysophospholipid/Lysosphingolipid Receptor. GPR63 expression has been reported in several brain regions, including caudate, frontal cortex, hypothalamus, midbrain, and thalamus, as well as in small intestine, stomach, and thymus. ESTs have been isolated from anaplastic oligodendroglioma, colon, and testis cancer libraries.

Bioinformatics

Entrez Human
Uniprot Human
Human
Human
Human
Product By Gene ID 81491
Alternate Names
  • probable G-protein coupled receptor 63
  • PSP24-2
  • brain expressed G-protein-coupled receptor PSP24 beta
  • PSP24BPSP24(beta)
  • PSP24-beta
  • G protein-coupled receptor 63

Pathways for GPR63

View related products by pathway and learn more about each of the pathways below.

Cell Motility

Research Areas for GPR63

Find related products by research area and learn more about each of the different research areas below.

GPCR

Bioinformatics Tool for GPR63

Discover related pathways, diseases and genes to GPR63. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
 
Vizit™, under license from BioVista Inc.